global opportunity here! DATAMETREX SUBSIDIARY CANNTOP AI FOCUSES ON CANNABIS
Datametrex AI Ltd.'s newly formed subsidiary, Canntop AI Inc., will leverage Nexalogy's strong experience working on AI solutions for the vaping sector. Canntop AI will continue to use Nexalogy's technology to become a leading provider of social data analysis in the cannabis space.
Nexalogy has a multiyear record of successfully working with various Canadian federal agencies including Health Canada. One of the programs Nexalogy has worked on with Health Canada was focused on the vaping industry. Nexalogy's technology targeted key trends and social discovery, allowing Health Canada to have deeper insight into usage and patterns. As a proven solution provider to the federal government, the company believes that it is well positioned to bid on new projects providing social data insights to multiple agencies. The cannabis sector is expected to grow significantly, generating massive amounts of social data that will need to be collected, scrubbed and analyzed.
The company created Canntop AI to focus on the cannabis sector as it has seen the positive results of its solutions and work in the vaping area and anticipates that the cannabis space will benefit strongly from its technology. Canntop AI will focus on the cannabis market, including insight and analytical data on cosmetics, CBD (cannabidiol), recreational and medical use, as well as consumables.
"This is a tremendous opportunity for Datametrex to build on existing relationships and previous contracts with various government agencies. We believe there will be tremendous demand by various groups for clear, concise and actionable social data analysis surrounding the cannabis sector. Creating Canntop AI demonstrates our commitment to becoming a global leader in this marketplace," says Andrew Ryu, chief executive officer and chairman of the company.